Nixon Peabody Trust CO Merck & Co., Inc. Transaction History
Nixon Peabody Trust CO
- $1.14 Billion
- Q1 2025
A detailed history of Nixon Peabody Trust CO transactions in Merck & Co., Inc. stock. As of the latest transaction made, Nixon Peabody Trust CO holds 82,017 shares of MRK stock, worth $6.39 Million. This represents 0.65% of its overall portfolio holdings.
Number of Shares
82,017
Previous 84,010
2.37%
Holding current value
$6.39 Million
Previous $8.36 Million
11.92%
% of portfolio
0.65%
Previous 0.71%
Shares
29 transactions
Others Institutions Holding MRK
# of Institutions
3,939Shares Held
1.86BCall Options Held
16MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA251MShares$19.5 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$16.1 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$9.41 Billion0.49% of portfolio
-
Geode Capital Management, LLC Boston, MA61.2MShares$4.76 Billion0.48% of portfolio
-
Morgan Stanley New York, NY44.2MShares$3.44 Billion0.32% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $197B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...